Results 71 to 80 of about 16,224 (212)
Movement Disorders, EarlyView.Abstract Background Emerging evidence implicates neuroinflammation in progressive supranuclear palsy (PSP) pathophysiology, with elevated cyto‐chemokines suggesting natural killer (NK) cell involvement. Methods We characterized peripheral NK in PSP (N = 11) versus Parkinson's disease (PD, N = 10) and healthy controls (HC, N = 8) at both ...
Marina Picillo +11 more
wiley +1 more source
4R-tau seeding activity reveals molecular subtypes in progressive supranuclear palsy
Nature CommunicationsProgressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by abnormal accumulation of the protein tau in the brain, leading to motor and cognitive symptoms that vary between individuals. The reasons for this clinical heterogeneity
Ivan Martinez-Valbuena +21 more
doaj +1 more source
Progressive Supranuclear Palsy Syndrome: An Overview
IBRO Neuroscience ReportsProgressive supranuclear palsy (PSP) is a neurodegenerative disease, commonly observed as a movement disorder in the group of parkinsonian diseases. The term PSP usually refers to PSP-Richardson’s syndrome (PSP-RS), the most typical clinical presentation.
Eduardo Ichikawa-Escamilla +2 more
doaj +1 more source
Asymmetric Upper Limb Dysfunction Demonstrated at the Bedside: A Phenomenology Video
Movement Disorders Clinical Practice, EarlyView.
Gero Lueg +4 more
wiley +1 more source
Movement Disorders, EarlyView.Abstract Parkinson's disease (PD) has been historically defined as a disease of striatal dopamine deficiency secondary to degeneration of dopaminergic neurons in the substantia nigra pars compacta, related to the presence of Lewy bodies and Lewy neurites.
Michele Matarazzo +10 more
wiley +1 more source
Challenges with the differential diagnosis of progressive supranuclear palsy and Parkinson’s disease
Анналы клинической и экспериментальной неврологии, 2017 Progressive supranuclear palsy (PSP) is a severe old-age neurodegenerativedisease that is characterized by pronouncedclinical polymorphism and has different phenotypes.
R. V. Magzhanov +5 more
doaj +1 more source
Movement Disorders, EarlyView.Abstract Background Differentiating progressive supranuclear palsy (PSP) from Parkinson's disease (PD) can be clinically challenging. In the neuroimaging field, radiomics has emerged as a promising approach to capture subtle microstructural and textural image alterations, improving differential diagnoses.
Chiara Camastra +8 more
wiley +1 more source
Reversible drug-induced progressive supranuclear palsy-like presentation: A report of three cases
Annals of Movement Disorders, 2019 Drugs, such as dopamine receptor blockers or dopamine depleters, produce a functional dopamine-deficient state mimicking parkinsonism, but presentation with a progressive supranuclear palsy (PSP) is a rare manifestation.
Shivani Rath, Deepika Joshi
doaj +1 more source
Qihuang Needle Therapy for Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial
Movement Disorders, EarlyView.Abstract Background Motor symptoms in Parkinson's disease (PD) often respond incompletely to medication, highlighting the need for effective adjunctive therapies. Acupuncture may offer benefits, but high‐quality evidence for specialized techniques such as Qihuang needle therapy is lacking.
Wanqing Peng +11 more
wiley +1 more source
Research on progressive supranuclear palsy
Chinese Journal of Contemporary Neurology and Neurosurgery, 2011 DOI：10.3969/j.issn.1672-6731.2011.01 ...
Yiming LIU, Jiazhen LI
doaj